ThemiRNA シーケンスおよびアッセイ市場は、2019 年の 1 億 9,231 万米ドルから 2027 年までに 4 億 6,899 万米ドルに達すると予想されます。 2020 年から 2027 年にかけて 11.9% の CAGR で成長すると推定されています。
miRNA は 20 ~ 30 ヌクレオチド長の小さな非コード RNA 分子であり、遺伝子制御において重要な役割を果たしています。メッセンジャー RNA (mRNA) と部分的に相補的であるため、遺伝子発現を下方制御する主要な機能を果たし、重要な細胞機能の主要なコントローラーとなります。 miRNA は、ウイルス感染、自己免疫疾患、発がんなどの病理学的プロセスに関連しています。したがって、新しい miRNA を同定するために広範な研究が行われています。 miRNA シークエンシングおよびアッセイ市場の成長は、主に miRNA アプリケーションの範囲の拡大やゲノミクス研究への資金の増加などの要因に起因しています。ただし、miRNA ベースの治療薬の送達、有効性、特異性に関連する課題が市場の成長を妨げると予測されています。
miRNA シークエンシングおよびアッセイ市場の有利な地域
市場洞察
MicroRNA アプリケーションの範囲の拡大
miRNA は、20 ~ 30 ヌクレオチド長の非コード低分子 RNA 分子のグループです。これらの分子は標的メッセンジャー RNA (mRNA) に結合し、遺伝子サイレンシングを引き起こし、それによって遺伝子発現を制御します。したがって、それらは細胞の生理機能と発生において重要な役割を果たします。 miRNA は、細胞の増殖、分化、アポトーシスなどのすべての細胞機能を制御します。それらは分化のプロセスに関与しており、組織の同一性を提供する上で重要な役割を果たします。したがって、miRNA は細胞型を識別する際の有用なマーカーであると考えられています。
さらに、miRNA はウイルス感染、自己免疫疾患、発がんなどの病理学的プロセスにも関連しています。そのうちのいくつかはがん遺伝子 (oncomiR) として機能し、他のいくつかは腫瘍抑制 miRNA として機能します。 miRNA の発現の変化は、さまざまな種類のがんの発生と相関しています。 miRNA と次世代シーケンス技術を組み合わせた、新しい種類のがんバイオマーカーとしての可能性が研究されています。これらは、がんの発生、進行、予後、診断、治療の評価において重要な役割を果たすと予測されています。さらに、いくつかのクラスの miRNA は、HIV、ヘンドラ ウイルス、結核、マラリアなどの病原体によって引き起こされる感染症の有望なバイオマーカーとしても浮上しています。
さらに、疾患の発症における miRNA の役割に関する発見により、 miRNA は、新しい治療アプローチの重要な標的です。癌や肝炎などの疾患に対する miRNA を標的としたいくつかの治療法が臨床段階に達しています。たとえば、Santaris Pharma は、C 型肝炎ウイルス (HCV) 感染の治療のために miR-122 を標的とする Miravirsen という名前の治療分子を開発しました。この分子は第 II 相臨床試験中です。したがって、miRNA の応用範囲の拡大が、miRNA シーケンシングおよびアッセイ市場の成長を促進しています。
製品ベースの洞察
miRNA シーケンシングおよびアッセイ市場は、製品ごとに次のようになります。ライブラリの準備と消耗品に分類されます。 2019 年は消耗品セグメントがより大きな市場シェアを占めましたが、ライブラリー調製セグメントは予測期間中に市場でより高い CAGR を記録すると予想されます。
miRNA シーケンシングおよびアッセイ市場、製品別 - 2019
テクノロジーベースの洞察
テクノロジーに基づいて、miRNA シーケンスおよびアッセイ市場は、合成によるシーケンス、ナノポア、およびイオン半導体シーケンスに分類されます。合成によるシーケンスセグメントは、2019年に市場で最大のシェアを占めました。ただし、ナノポアセグメントは、2020~2027 年に市場で最も高い CAGR を記録すると予想されています。
エンドユーザーベースの洞察
エンドユーザーに基づいた、miRNA シーケンスおよびアッセイ市場研究機関、学術界、CROに分かれています。研究機関部門は 2019 年に市場で最大のシェアを占め、2020 年から 2027 年にかけて市場で最高の CAGR を記録すると推定されています。
戦略的洞察
コラボレーションは、これは、miRNA シーケンシングおよびアッセイ市場のプレーヤーが世界中の顧客ベースを拡大するために採用した主要な戦略であり、これにより、ブランド名を世界的に維持することも可能になります。
miRNA シーケンシングおよびアッセイ市場 – 製品別
- ライブラリの準備
- 消耗品
miRNA シーケンシングおよびアッセイ市場 - テクノロジー別
- 合成によるシーケンシング
- イオン半導体シーケンシング
< li>ナノポア
miRNAシーケンシングおよびアッセイ市場 - エンドユーザー別
- 研究機関
- CRO
< li>学術
miRNA シーケンシングおよびアッセイ市場 - 地理別
- 北米
- 米国< /li>
- カナダ
- メキシコ
- ヨーロッパ
- フランス
- ドイツ
- イタリア
- 英国
- スペイン
- その他のヨーロッパ
- アジア太平洋 (APAC)
- 中国
- インド
- 韓国
- 日本
- オーストラリア
- その他のアジア太平洋
- 中東およびアフリカ (MEA)
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- 中東およびアフリカの残りの地域
- 南および中央アメリカ
- ブラジル
- アルゼンチン
< li>その他の中南米
会社概要
- Illumina Inc.
- Thermoフィッシャーサイエンティフィック株式会社
- キアゲン
- パーキンエルマー株式会社
- タカラバイオ株式会社
- ニューイングランドバイオラブズ
- NorgenBiotek Corp
- TriLinkBioTechnologies Inc
- Lexogen GmbH
- Oxford Nanopore Technologies
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
miRNA is a small non-coding RNA molecule of 20–30-nucleotide length, and it plays an important role in gene regulation. As it is partially complementary to messenger RNA (mRNA), it serves a major function of down-regulating the gene expression, which makes it a key controller of important cellular functions. miRNAs are associated with pathological processes such as viral infections, autoimmune diseases, and carcinogenesis. Thus, extensive research is being conducted to identify new miRNAs.
The growth of the miRNA sequencing and assay market is mainly attributed to the factors such widening range of miRNA applications and rise in funding for genomics research. However, challenges related to delivery, efficacy, and specificity of miRNA-based therapeutics is projected to deter the market growth.
The GMP cytokines market majorly consists of the players such as Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen, Perkin Elmer, Inc., Takara Bio Inc., New England Biolabs, Norgen Biotek Corp, TriLink BioTechnologies Inc, Lexogen GmbH, and Oxford Nanopore Technologies among others.
The List of Companies - MiRNA Sequencing And Assay Market
- Illumina Inc.
- Thermo Fisher Scientific Inc.
- Qiagen
- Perkin Elmer Inc.
- Takara Bio Inc.
- New England Biolabs
- NorgenBiotek Corp
- TriLinkBioTechnologies Inc
- Lexogen GmbH
- Oxford Nanopore Technologies
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Feb 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Feb 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Feb 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Feb 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)